Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Kinesio Taping for Upper Limb Function of Stroke Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03935113
Recruitment Status : Unknown
Verified April 2019 by Taipei Medical University WanFang Hospital.
Recruitment status was:  Not yet recruiting
First Posted : May 2, 2019
Last Update Posted : May 2, 2019
Sponsor:
Information provided by (Responsible Party):
Taipei Medical University WanFang Hospital

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Patients with stroke in the brain, due to central nervous system damage, lack of correct action patterns, limited joint movement of upper limbs, affecting the patient's performance. The Kinesio taping effect is to facilitate the muscle activity of upper limb. This program is intended to provide a treatment for patients with chronic stroke, and to observe their upper limb movements before and after using the Kinesio taping.

Condition or disease Intervention/treatment Phase
Stroke Other: Kinesio taping Not Applicable

Detailed Description:
Motor impairment is the main cause of disability after stroke, leading to major health problems. Research has shown that the most common consequence of stroke is the paresis of limbs.The ability to live independently after a stroke depends on the recovery of motor functions,particularly those of the upper limb.The core concept of the Kinesio taping is to influence the brain through the sensory input, stimulate the nervous system, and improve the motor performance of the stroke patient.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effects of Kinesio Taping for Upper Limb Function of Stroke Patients
Estimated Study Start Date : May 1, 2019
Estimated Primary Completion Date : September 30, 2019
Estimated Study Completion Date : July 30, 2020
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: KT group
The paretic upper limb is a common consequence of stroke that increases activity limitation.
 Other: Kinesio taping
In KT group, KT was applied using the insertion-origin muscle and space-correction technique of affected upper limb with stroke patients.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Change in Fugl-Meyer Assessment (FMA) from pre to post-intervention. [ Time Frame: up to 30 minutes. ]
    The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia.

  2. Change in Action Research Arm Test (ARAT) from pre to post-intervention. [ Time Frame: up to 30 minutes. ]
    The Action Research Arm Test (ARAT) is an evaluative measure to assess specific changes in limb function among post-stroke hemiplegia.

  3. Change in Box and Block Test (BBT) from pre to post-intervention. [ Time Frame: up to 30 minutes. ]
    The Box and Block Test (BBT) measures unilateral gross manual dexterity for stroke patients.


Secondary Outcome Measures :
  1. Change in Motor Activity Log (MAL) from pre to post-intervention. [ Time Frame: up to 20 minutes. ]
    The Motor Activity Log (MAL) is a semi-structured interview to assess arm function.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Post-stroke hemiplegia, at least 6 months since onset
  • Ability to communicate and understand instructions.

Exclusion Criteria:

  • Skin problems, wounds, or infection on the affected upper limb.
  • The experience of using the Kinesio taping.
  • A history of allergy tothe Kinesio taping.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

No Contacts or Locations Provided
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier: NCT03935113    
Other Study ID Numbers: N201811021
First Posted: May 2, 2019    Key Record Dates
Last Update Posted: May 2, 2019
Last Verified: April 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
 Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases